Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (GB:0A7L)
LSE:0A7L
Irhythm Technologies (0A7L) Share Price & Analysis
0 Followers
0A7L Stock Chart & Stats
Day’s Range$117.09 - $117.11
52-Week Range― - ―
Previous Close$113.2
Volume5.00
Average Volume (3M)N/A
Market Cap
$3.60B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 02, 2024EPS Estimate
-$0.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$135.56Price Target Upside15.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Irhythm Technologies News
Bulls Say, Bears Say
Bulls Say
Financial StrategyIRTC announced a $450M convertible debt offering to be used for general corporate purposes, to strengthen the balance sheet, and to reduce its cost of capital.
Market ExpansionInternational market entrance is progressing with plans for early-2025 entry in Japan, expected to drive growth for IRTC.
Strategic PartnershipsThe partnership with Signify Health and the potential for future similar deals is a positive move, with a full launch of the collaboration potentially being material to IRTC's top line.
Bears Say
Company GuidanceIRTC lowered its year-over-year growth forecast by 1 percentage point to 17-19%.
Financial PerformanceConvertible Debt Offering resulted in increased interest expense, leading to a decrease in estimated EPS for the years 2024 to 2026.
Operational EfficiencyMargins came in weaker than expected as Zio Monitor adoption drove near-term inefficiencies.
---
Options Prices
Currently, No data available
---
Ownership Overview
3.16% Insiders
42.00% Mutual Funds
16.34% Other Institutional Investors
38.50% Public Companies and
Individual Investors
0A7L FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Currently, no data Available
What is Irhythm Technologies’s market cap?
Currently, no data Available
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is May 02, 2024 which is in 6 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Feb 22, 2024. The company reported -$1.26 earnings per share for the quarter, missing the consensus estimate of -$0.579 by -$0.681.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -$0.97.
How many shares outstanding does Irhythm Technologies have?
Currently, no data Available
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$1.26 in its last earnings report, missing expectations of -$0.579. Following the earnings report the stock price went down -4.25%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Among the largest hedge funds holding Irhythm Technologies’s share is Sands Capital Management LLC. It holds Irhythm Technologies’s shares valued at 240M.
---
Irhythm Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$135.56 (15.75% Upside)
$135.56 (15.75% Upside)
Blogger Sentiment
Bullish
GB:0A7L Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $6.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.72%
12-Months-Change
Fundamentals
Return on Equity
-54.86%
Trailing 12-Months
Asset Growth
-3.36%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
---
0A7L Company Deck
---
0A7L Earnings Call
Q4 2024
0:00 / 0:00
---
0A7L Stock 12 Months Forecast
Average Price Target
$135.56
▲(15.75% Upside)
Technical Analysis
Best Analysts Covering 0A7L
1 Year
1 Year Success Rate
8/14 ratings generated profit
1 Year Average Return
+2.01%
assigned a buy rating 2 months ago
Copying David Rescott's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.01% per trade.
---